research JAK inhibitors in dermatology: The promise of a new drug class 355 citations , January 2017 in “Journal of the American Academy of Dermatology” JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.
research Emerging Topical and Systemic JAK Inhibitors in Dermatology 277 citations , December 2019 in “Frontiers in Immunology” JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.
research JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis 223 citations , September 2018 in “Rheumatology” JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.
research Under Development JAK Inhibitors for Dermatologic Diseases 14 citations , January 2020 in “Mediterranean Journal of Rheumatology” New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.
research JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology January 2026 in “Medicina” JAK inhibitors show promise for treating various skin disorders effectively and safely.
learn Baricitinib JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases
community Is it ok to take Xeljanz (A jak inhibitor) while taking finasteride? in Finasteride 2 upvotes 9 years ago The conversation is about whether it is safe to take Xeljanz, a JAK inhibitor, while also taking finasteride for hair loss. The concern is that Xeljanz weakens the immune system, which could be risky.